TREATMENT OF COGNITIVE DEFICIENCY IN MUCOPOLYSACCHARIDOSE TYPE IIIA BY INTRATHECAL ADMINISTRATION OF HEPARAN N-SULFATASE

MA55000AUndetermined Publication Date: 2022-03-23SHIRE HUMAN GENETIC THERAPIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA55000
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2015-07-20
Filing Date
2016-07-20
Publication Date
2022-03-23
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.